Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1450 of 3173 entries
View as:

A Study To Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01959594 Org: User:
Start: 11/30/13 End: 03/31/14 Due: 03/31/15

Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01882439 Org: User:
Start: 08/31/13 End: 04/30/16 Due: 04/30/17

Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)

Phase: N/A Priority: Normal
NCT ID: NCT00730665 Org: User:
Start: 01/31/08 End: 10/31/08 Due: 10/31/09

Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults

Phase: N/A Priority: Normal
NCT ID: NCT00527046 Org: User:
Start: 12/31/99 End: 10/31/01 Due: 10/31/02

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

Phase: N/A Priority: Normal
NCT ID: NCT05047601 Org: User:
Start: 09/09/21 End: 04/12/22 Due: 04/12/23

Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01314885 Org: User:
Start: 01/31/11 End: 12/31/11 Due: 12/31/12

Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00883896 Org: User:
Start: 06/18/09 End: 02/18/11 Due: 02/18/12

Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT00002075 Org: User:
Start: - End: - Due: -

Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00715039 Org: User:
Start: 10/31/03 End: 05/31/04 Due: 05/31/05

A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05643885 Org: User:
Start: 08/31/22 End: 08/30/24 Due: 08/30/25

Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00673049 Org: User:
Start: 05/31/08 End: 04/30/12 Due: 04/30/13

A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI

Phase: N/A Priority: Normal
NCT ID: NCT00483028 Org: User:
Start: 06/30/04 End: 01/31/07 Due: 01/31/08

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT00824590 Org: User:
Start: 02/28/09 End: 10/31/09 Due: 10/31/10

A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product Testers

Phase: N/A Priority: Normal
NCT ID: NCT01023100 Org: User:
Start: 03/31/10 End: 03/31/10 Due: 03/31/11

Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)

Phase: N/A Priority: Normal
NCT ID: NCT01229436 Org: User:
Start: 12/31/10 End: 10/31/12 Due: 10/31/13

Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation

Phase: N/A Priority: Normal
NCT ID: NCT00435747 Org: User:
Start: - End: - Due: -

TBE Seropersistence up to 10 Years After First Booster in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01582698 Org: User:
Start: 04/30/12 End: 06/30/15 Due: 06/30/16

A Phase 1 Absolute Bioavailability Study For Oral Crizotinib In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01168934 Org: User:
Start: 08/31/10 End: 09/30/10 Due: 09/30/11

An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Phase: N/A Priority: Normal
NCT ID: NCT00932893 Org: User:
Start: 09/30/09 End: 01/31/16 Due: 01/31/17

Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients

Phase: N/A Priority: Normal
NCT ID: NCT04428424 Org: User:
Start: 07/05/20 End: 08/30/20 Due: 08/30/21

Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women

Phase: N/A Priority: Normal
NCT ID: NCT00147524 Org: User:
Start: 10/31/03 End: 05/31/05 Due: 05/31/06

A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin

Phase: N/A Priority: Normal
NCT ID: NCT01262690 Org: User:
Start: 11/30/10 End: 09/30/11 Due: 09/30/12

Open Label Safety Study in Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT03266588 Org: User:
Start: 08/30/17 End: 07/15/19 Due: 07/15/20

Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IV

Phase: N/A Priority: Normal
NCT ID: NCT01073618 Org: User:
Start: 03/31/06 End: 10/31/09 Due: 10/31/10

Axitinib Pharmacokinetics in Chinese Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00919204 Org: User:
Start: 08/31/09 End: 08/31/09 Due: 08/31/10